Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-016197

Options or other derivatives

  • Director acquired 20,543 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Humphries William D. Director 2024-06-06 Grant or award · Stock Option (Right to Buy) +15,750 15,750 D
Humphries William D. Director 2024-06-06 Grant or award · Restricted Stock Units +4,793 4,793 D
Loading xslF345X05/form4-06102024_040613.xml…